Partnering with AstraZeneca Australia
AstraZeneca strives to consistently be the number one company in Australia for companies to partner and collaborate with. Across our biologics and small molecule research, we are concentrating our scientific efforts and the weight of our investment, including business development, on three core therapy areas:
- Cardiovascular and Metabolic Disease (CVMD)
- Respiratory, Inflammation & AutoImmune (RIA)
We partner with multiple stakeholders around the world including academia, governments, industry, scientific organisations and patient groups to access the best science and molecules and to stimulate innovation.
Learn more about AstraZeneca's global partnering approach and for our key global contacts.
For further discussions or queries on local partnering approach, please navigate to the Contact Us page, select 'About Partnering' and submit your query.